Immunome

Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies - The combined company, which will operate as Immunome, will feature a synergistic platform expected to enable the development of best-in-class targeted cancer therapies across multiple modalities - Clay B.…

Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity See more here

Immunome Reports First Quarter 2023 Financial Results See more here

Immunome Reports Fourth Quarter and Full Year 2022 Financial Results See more here

Immunome to Present at 13th Annual World ADC London Conference See more here

Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board Advisory board to help guide selection of novel antibody-target pairs for ADC and T cell redirection modalities See more here

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets - Multi-year collaboration to identify up to 10 novel target-antibody pairs leveraging Immunome’s Discovery Engine - Immunome to receive $30M upfront payment with potential for further platform access and option payments as well as development, commercial, and sales-based…

Immunome Reports Third Quarter 2022 Financial Results See more here

Immunome Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting - IMM20059, Immunome’s epsin 1 (EPN1)-specific antibody, binds to the surface of multiple tumor cell lines, including lung, breast and prostate cancers in preclinical testing - EPN1 appears to play…

Immunome Announces Publication in Clinical & Translational Immunology Highlighting B Cell Repertoires in Patients with Breast Cancer - The study demonstrates the importance of tumor and lymph node-derived B cells for the discovery of antibodies directed at potentially novel targets - The study results provide a framework for understanding the evolution of…